These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32941958)

  • 1. Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.
    Demizu Y; Imai R; Kiyohara H; Matsunobu A; Okamoto M; Okimoto T; Tsuji H; Ohno T; Shioyama Y; Nemoto K; Nakano T; Kamada T;
    Radiother Oncol; 2021 Jan; 154():1-5. PubMed ID: 32941958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
    Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
    JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon ion radiotherapy for sacral chordoma.
    Imai R; Kamada T; Sugahara S; Tsuji H; Tsujii H
    Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S48-54. PubMed ID: 21427182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.
    Mima M; Demizu Y; Jin D; Hashimoto N; Takagi M; Terashima K; Fujii O; Niwa Y; Akagi T; Daimon T; Hishikawa Y; Abe M; Murakami M; Sasaki R; Fuwa N
    Br J Radiol; 2014 Jan; 87(1033):20130512. PubMed ID: 24288399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon Ion Radiotherapy for sacral chordoma: a systematic review of the literature.
    Evangelisti G; Sartini F; Bandiera S; Barbanti Brodano G; Griffoni C; Girolami M; Pipola V; Gasbarrini A
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 3):353-361. Congress of the Italian Orthopaedic Research Society. PubMed ID: 33261300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies.
    Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
    Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
    Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
    Kinoshita H; Yonemoto T; Yamada S; Imai R
    Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of high dose carbon-ion radiation therapy for unresectable upper cervical (C1-2) chordoma.
    Aoki S; Koto M; Ikawa H; Imai R; Tokuhiko O; Shinoto M; Takiyama H; Yamada S; Tsuji H
    Head Neck; 2022 Oct; 44(10):2162-2170. PubMed ID: 35734902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone.
    Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R
    Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases.
    Imai R; Kamada T; Araki N;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):322-327. PubMed ID: 27084649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma.
    Lorenzo C; Andrea P; Barbara V; Denis P; Rosaria FM; Piero F; Viviana V; Alberto I; Mario C; Brugnatelli S; Tommaso D; Bugada D; Marcello M; Mario A; Francesca V; Roberto O; Paolo D
    World J Surg Oncol; 2016 Aug; 14(1):211. PubMed ID: 27507254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
    Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
    Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
    Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
    Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
    Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
    Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.
    Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
    Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
    Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer.
    Chung SY; Takiyama H; Kang JH; Chang JS; Min BS; Tsuji H; Yamada S; Koom WS
    Sci Rep; 2022 Feb; 12(1):1845. PubMed ID: 35115612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.